for MZ SR:

for the AOPP:

The meeting took place at the request of the AOPP (Association for the Protection of Patients' Rights).
The meeting was opened by PharmDr. Rastislav Pullmann Director The Department of Categorisation of Pricing and Drug Policy and asked the AOPP to present its requirements.
Discussion on the issues raised:

  1. JUDr. Madajová pointed out a persistent non-compliant condition in the possibility of prescribing series-made orthopaedic shoes with diabetic treatment. The list of categorised medical devices contains codes registered by the manufacturer of Cebo Holding and this manufacturer no longer exists.
  2. PharmDr. Pullmann explained the categorization process in which a medical device can be listed only upon request from the manufacturer.
  3. Mgr. MVDr. Jaďuď informed the AOPP about the upcoming changes to the tailor-made list of medical devices in which it will be in sub-group I1.1 Footwear orthopaedic individual, single semi-finished and also footwear with diabetic treatment.
  4. MZ SR proposes AOPP to initiate series orthopaedic footwear manufacturers with diabetic treatment to submit applications to subgroup J1.2.

Finally, they agreed on the need for mutual communication, including through working meetings in the Slovak Ministry of Health, where there is a will to invite representatives of individual institutions on specific issues and to respond to current topics in the field of medical devices. The meeting was closed by the director of OKCLP PharmDr. Rastislav Pullmann.
He wrote: Mgr. MVDr. Branislav Jajuď
They verified for AOPP: JUDr. Eva Madajová
Approval: PharmDr. Rastislav Pullmann